Comprehensive knowledge-based cancer care
Location: United States
Employees: 51-200
Total raised: $113M
Founded date: 2015
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.01.2026 | - | $43M | Socium Ven... |
| 02.10.2024 | - | $45M | - |
| 21.04.2021 | Series A | $25M | - |
Mentions in press and media 16
| Date | Title | Description |
| 15.01.2026 | VieCure Raises $43 Million to Help Democratize Access to the Highest Caliber Cancer Care in Community Practices | - |
| 13.01.2026 | VieCure Accelerates AI Precision Oncology with $43 Million Infusion | VieCure secures $43 million. Its AI-powered Halo Intelligence platform is poised to transform community cancer care. This funding addresses critical operational complexities in clinics, which serve most U.S. cancer patients. The platform bo... |
| 12.01.2026 | Mitch Rales Leads $43M Round to Scale VieCure’s AI Oncology Platform | What You Should Know: – VieCure has raised $43M led by Mitch Rales (co-founder of Danaher) and Northpond Ventures. The funding will scale VieCure’s Halo Intelligence™ platform, an AI-powered clinical decision support system that has already... |
| 12.01.2026 | VieCure: $43 Million Raised To Expand AI-Powered Precision Cancer Care In Community Practices | VieCure announced it has raised $43 million to accelerate the rollout of its software platform designed to help community oncology clinics deliver precision-medicine care with greater speed and consistency. The financing was led by Mitch Ra... |
| 12.01.2026 | VieCure Raises $43M in Funding | VieCure, a Denver, CO-based provider of software platforms for oncology care, raised $43M in funding. The round was led by Mitch Rales, and Northpond Ventures, with participation from Durable Capital Partners, Socium Ventures and Sator Grov... |
| 08.10.2024 | Navigating the Future of Oncology and Healthcare Production Amidst Challenges | In the world of healthcare, innovation is the lifeblood. Companies like VieCure and Fresenius are at the forefront, pushing boundaries and adapting to challenges. VieCure, with its recent $45 million funding, is revolutionizing community on... |
| 03.10.2024 | VieCure Secures 45M for AI-Enabled Community Oncology Care Platform | What You Should Know: – VieCure Inc., pioneer of next-generation intelligence platforms that democratize community oncology care, today announced the completion of a $45 million financing led by Northpond Ventures and the appointment of ind... |
| 02.10.2024 | VieCure Raises $45M in Financing | VieCure, a Denver, CO-based provider of an intelligence platform that aims to democratize community oncology care, raised $45M in funding. The round was led by Northpond Ventures. The company intends to use the funds to scale commercial ope... |
| 11.04.2024 | VieCure Streamlines Cancer Care with Integrated E-Prescribing and Medication Management | What You Should Know: – VieCure, a leading cancer care company, announced today that it’s integrating DrFirst’s e-prescribing and medication management solutions into its clinical decision support system. – VieCure is a well-established poi... |
| 01.06.2023 | VieCure Launches Pilot Program with Clarified Precision Medicine at ALCC to Accelerate the Adoption of Precision Oncology | With a focus on Patients and Community Oncologists, the Partners will Turn a Greater Number of Molecular Test Results Into Actionable Therapy VieCure, a cancer care company with a market-leading artificial intelligence, informatics, and cli... |
Show more